自由体位下罗哌卡因、舒芬太尼在瘢痕子宫再次分娩中的镇痛效果及安全性

doi:10.3760/cma.j.issn.1007-1245.2023.03.014

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (3): 361-364.DOI: 10.3760/cma.j.issn.1007-1245.2023.03.014

自由体位下罗哌卡因、舒芬太尼在瘢痕子宫再次分娩中的镇痛效果及安全性

毋琳琳

焦作市妇幼保健院产科三区，焦作　454000

收稿日期:2022-10-08 出版日期:2023-02-01 发布日期:2023-03-03
通讯作者: Email：wulinlinwu@126.com
基金资助:
河南省医学科技攻关项目（2021001620）

Analgesic effects and safety of ropivacaine and sufentanil during the rebirth of scarred uterus in the free body position

Wu Linlin

Ward 3, Department of Obstetrics, Maternal and Child Health Hospital of Jiaozuo City, Jiaozuo 454000, China

Received:2022-10-08 Online:2023-02-01 Published:2023-03-03
Contact: Email: wulinlinwu@126.com
Supported by:
Medical Science and Technology Project of Henan Province (2021001620)

摘要/Abstract

摘要：

目的　观察自由体位下应用罗哌卡因、舒芬太尼对瘢痕子宫再次分娩的镇痛效果及安全性。方法　本研究为随机对照试验。选取2021年3月至2022年3月期间焦作市妇幼保健院收治的110例瘢痕子宫再次妊娠患者为研究对象，经抽签法将患者按1∶1比例分为A组［55例，年龄（30.23±0.16）岁］、B组［55例，年龄（30.11±0.35）岁］。两组均在自由体位下进行分娩镇痛，A组采用罗哌卡因镇痛，B组采用舒芬太尼镇痛。比较两组的镇痛效果、妊娠结局及预后情况。行χ²检验、独立样本t检验。结果　在不同镇痛方式下，A组镇痛10 min、30 min、60 min、90 min后的视觉模拟疼痛评分量表（VAS）评分［（5.72±0.31）分、（5.04±0.33）分、（4.45±0.31）分、（3.66±0.41）分］略低于B组［（5.75±0.28）分、（5.05±0.26）分、（4.52±0.28）分、（3.72±0.36）分］，但差异均无统计学意义（均P>0.05）。镇痛后A组患者的丙二醛（MDA）水平（411.36±10.15）nmol/ml低于B组（435.47±10.38）nmol/ml（t=12.316，P<0.001）、超氧化物歧化酶（SOD）水平（385.32±10.16）U/L高于B组（341.36±10.31）U/L（t=22.523，P<0.001）。A组新生儿娩出后1 min、5 min、10 min时的Apgar评分［（8.33±0.16）分、（8.85±0.47）分、（9.11±0.46）分］高于B组［（7.64±0.28）分、（8.23±0.16）分、（8.82±0.41）分］，差异均有统计学意义（均P<0.05）。A组不良预后发生率9.09%（5/55）低于B组21.82%（12/55）（χ²=6.201，P=0.013）。结论　自由体位下对瘢痕子宫再次妊娠产妇实施罗哌卡因、舒芬太尼镇痛的效果相当，但相比之下，在静脉自控镇痛泵中应用罗哌卡因的应激反应更轻，安全性更高，对改善母婴结局更具积极意义。

关键词:

瘢痕子宫, 再次妊娠, 自由体位, 罗哌卡因, 舒芬太尼, 镇痛效果, 安全性

Abstract:

Objective　To observe the analgesic effects and safety of ropivacaine and sufentanil during the rebirth of scarred uterus in the free body position. Methods　It was a randomized controlled trial. A total of 110 re-pregnancy patients with scarred uterus admitted to Maternal and Child Health Hospital of Jiaozuo City from March 2021 to March 2022 were selected as the research objects, and they were divided into group A [55 cases, with an age of (30.23±0.16) years old] and group B [55 cases, with an age of (30.11±0.35) years old] according to the proportion of 1∶1 by drawing lots. Both groups were given birth analgesia in the free body position. Group A was given ropivacaine for analgesia, and group B was given sufentanil. The analgesic effects, pregnancy outcomes, and prognosis of the two groups were compared. χ² test and independent sample t test were used. Results　Under different analgesia modes, the Visual Analog Scale (VAS) scores in group A 10 min, 30 min, 60 min, and 90 min after analgesia [(5.72±0.31) points, (5.04±0.33) points, (4.45±0.31) points, and (3.66±0.41) points] were slightly lower than those in group B [(5.75±0.28) points, (5.05±0.26) points, (4.52±0.28) points, and (3.72±0.36) points], but there were no statistically significant differences (all P>0.05). The level of malondialdehyde (MDA) in group A was lower than that in group B [(411.36±10.15) nmol/ml vs. (435.47±10.38) nmol/ml] (t=12.316, P<0.001), but the level of superoxide dismutase (SOD) was higher than that in group B [(385.32±10.16) U/L vs. (341.36±10.31) U/L] (t=22.523, P<0.001). The neonatal Apgar scores in group A 1 min, 5 min, and 10 min after birth [(8.33±0.16) points, (8.85±0.47) points, and (9.11±0.46) points] were higher than those in group B [(7.64±0.28) points, (8.23±0.16) points, and (8.82±0.41) points], with statistically significant differences (all P<0.05). The incidence of adverse prognosis in group A was 9.09% (5/55), which was lower than that in group B [21.82% (12/55)] (χ²=6.201, P=0.013). Conclusion　The analgesic effects of ropivacaine and sufentanil on re-pregnant women with scarred uterus in the free body position are similar, but in contrast, the stress response of ropivacaine used in intravenous patient-controlled analgesia pump is lighter, the safety is higher, and it is more positive in improving the maternal and infant outcomes.

Key words:

Scarred uterus, Re-pregnancy, Free body position, Ropivacaine, Sufentanil, Analgesic effect, Safety

毋琳琳.

自由体位下罗哌卡因、舒芬太尼在瘢痕子宫再次分娩中的镇痛效果及安全性 [J]. 国际医药卫生导报, 2023, 29(3): 361-364.

Wu Linlin.

Analgesic effects and safety of ropivacaine and sufentanil during the rebirth of scarred uterus in the free body position [J]. International Medicine and Health Guidance News, 2023, 29(3): 361-364.

参考文献

[1] 魏素花,许碧云,郑明明.瘢痕子宫孕妇选择阴道分娩的预测分析及对分娩结局的影响[J].中国计划生育和妇产科,2020,12(3):74-78. DOI:10.3969/j.issn.1674-4020.2020. 03.20.
[2] El Agwany AS. Gynecological and postpartum ultrasonography of cesarean uterine scar defects: a pictorial essay[J]. J Ultrasound, 2020, 23(4):613-619. DOI: 10.1007/s40477-019-00403-3.
[3] 黄贤好,叶晓华,林欣婷.自由体位分娩联合责任制产程管理对瘢痕子宫再妊娠产妇阴道试产成功率和睡眠质量的影响[J].世界睡眠医学杂志,2022,9(4):677-679. DOI:10.3969/j.issn.2095-7130.2022.04.030.
[4] 向波,俞瑾,陈虎.全程硬膜外分娩镇痛在瘢痕子宫再次妊娠阴道试产中的应用[J].中国病案,2021,22(11):94-97. DOI:10.3969/j.issn.1672-2566.2021.11.034.
[5] 中华医学会计划生育学分会.剖宫产术后子宫瘢痕憩室诊治专家共识[J].中华妇产科杂志,2019,54(3):145-148. DOI:10.3760/cma.j.issn.0529-567x.2019.03.001.
[6] Ducoulombier V, Chiquet R, Graf S, et al. Usefulness of a Visual Analog Scale for measuring anxiety in hospitalized patients experiencing pain: a multicenter cross-sectional study[J]. Pain Manag Nurs, 2020, 21(6):572-578. DOI: 10.1016/j.pmn.2020.03.004.
[7] Sun YF, Chang Q, Wu QJ, et al. Association between maternal antenatal depression and neonatal Apgar score: a systematic review and meta-analysis of prospective cohort studies[J]. J Affect Disord, 2021, 278:264-275. DOI: 10.1016/j.jad.2020.09.054.
[8] 马丽萍,张辰晨,程义玲,等.硬膜外麻醉无痛分娩、剖宫产和自然分娩对盆底组织功能的影响[J].现代生物医学进展,2021,21(11):2121-2124. DOI:10.13241/j.cnki.pmb.2021.11.027.
[9] 徐学军,包晓红,向彩云.决定紧急剖宫产术至胎儿娩出间隔时间的相关因素及对新生儿预后的影响[J].中国妇幼保健,2021,36(9):2080-2083. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.09.040.
[10] 张敦欣,周彬.五音疗法配合自由体位分娩对初产妇分娩控制感及盆底功能的作用[J].国际医药卫生导报,2021,27(2):193-198. DOI:10.3760/cma.j.issn.1007-1245.2021. 02.010.
[11] 徐淑兰,尹军,于永生,等.腰硬联合阻滞分娩镇痛中规律间断注射舒芬太尼联合罗哌卡因对分娩结局、产间发热及镇痛效果的影响[J].广西医学,2020,42(9):1096-1099. DOI:10.11675/j.issn.0253-4304.2020.09.10.
[12] 陈晓丽,陈琼,方洁,等.罗哌卡因联合舒芬太尼自控镇痛泵对高龄孕妇无痛分娩疼痛强度及分娩结局的作用[J].中国妇幼保健,2021,36(10):2404-2406. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.10.068.
[13] 代虹,韩新,吕袁凯,等.程控硬膜外脉冲式输注不同剂量罗哌卡因复合舒芬太尼行阶梯式分娩镇痛对母婴的影响[J].临床麻醉学杂志,2020,36(10):975-979. DOI:10.12089/jca.2020.10.009.
[14] 王占晖,刘玉梅,刘雪.利多卡因复合盐酸罗哌卡因与枸橼酸舒芬太尼对产妇自控硬膜外分娩镇痛效果及对泌乳功能的影响[J].河北医学,2020,26(1):23-27. DOI:10.3969/j.issn.1006-6233.2020.01.006.
[15] 潘永英,王青宁,区信栩,等.低浓度罗哌卡因用于分娩镇痛时对产力的影响[J].国际麻醉学与复苏杂志,2020,41(2):164-168. DOI:10.3760/cma.j.issn.1673-4378.2020. 02.008.

自由体位下罗哌卡因、舒芬太尼在瘢痕子宫再次分娩中的镇痛效果及安全性

Analgesic effects and safety of ropivacaine and sufentanil during the rebirth of scarred uterus in the free body position

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

[1]	刘晓卉. 小剂量硝酸甘油联合氯吡格雷治疗冠心病心绞痛患者的疗效及安全性评价 [J]. 国际医药卫生导报, 2023, 29(4): 549-553.
[2]	刘辉王珍珍赵亚非. 临床药师参与的用药管理对急性脑梗死介入术后患者用药规范性、用药依从性及安全性的影响 [J]. 国际医药卫生导报, 2023, 29(4): 564-568.
[3]	郭哲义, 邓娇娇. 不同浓度舒芬太尼联合腹横肌平面阻滞对剖宫产术后镇痛的效果研究[J]. 国际医药卫生导报, 2022, 28(3): 311-314.
[4]	孙丽芳. 金振口服液联合抗生素对小儿支原体肺炎的临床治疗效果[J]. 国际医药卫生导报, 2022, 28(20): 2853-2857.
[5]	白延平郭娅娅. 半量瑞替普酶静脉溶栓对急性心肌梗死患者血流动力、循环内皮细胞及安全性的影响[J]. 国际医药卫生导报, 2022, 28(18): 2600-2603.
[6]	赵柳燕宋守君薛海波. 分子靶向药物治疗难治性甲状腺癌的疗效及安全性的meta分析[J]. 国际医药卫生导报, 2022, 28(17): 2369-2376.
[7]	郑现霞杜冬梅韩丰阳. 椎旁神经阻滞复合全身麻醉对胸中下段食管癌患者术后苏醒质量及镇痛效果的影响[J]. 国际医药卫生导报, 2022, 28(17): 2470-2473.
[8]	黎笑峰, 梁燕红, 王源. 无痛分娩产时发热产妇第二产程积极干预的临床实践[J]. 国际医药卫生导报, 2022, 28(12): 1746-1748.
[9]	潘小龙, 李晓, 衡宝利, 朱光建, 黄振, 吴凡宇. 无管化与传统PCNL治疗肾、输尿管上段结石的临床研究[J]. 国际医药卫生导报, 2022, 28(10): 1377-1380.
[10]	李红军. 不同时期肺表面活性物质联合NCPAP治疗NRDS的临床疗效及安全性分析[J]. 国际医药卫生导报, 2022, 28(10): 1414-1417.
[11]	黄隽, 马立强, 陈光明, 吴再新, 方桦, 欧琼霞. 新生儿动静脉同步换血模拟装置的设计与应用[J]. 国际医药卫生导报, 2021, 27(6): 852-855.